With its usual strong and international presence and expertise WÖRWAG Pharma participated again in the “46^th Annual Meeting of the European Association for the Study of Diabetes” (EASD). This year’s big annual EASD-Meeting of European Diabetologists took place in Stockholm, Sweden from the 20^th to 24^th of September.

The medium-sized family-owned pharmaceutical company from Böblingen is specialized in the treatment of Diabetes and its concomitant disorders. WOERWAG Pharma is present in 34 countries worldwide. This year, operations started in Brazil.

In Stockholm the WÖRWAG-Booth was occupied with an international crew that represented several countries. It was both a destination and a “Meeting Point” for the convention-participants across the globe. At the booth, an international exchange of experiences took place, and visitors received the most up-to-date expert information about the extensive product portfolio of the company.